Financial statements Imunotop Pl
Balance sheet data of IMUNOTOP PL
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
|---|---|---|---|---|---|
| Total assets | 321 114,71 | 244 024,85 | 282 968,40 | 219 287,11 | 231 117,67 |
| A. Fixed assets | 56 334,41 | 44 936,57 | 31 663,69 | 22 233,37 | 12 803,05 |
| B. Current assets | 264 780,30 | 199 088,28 | 251 304,71 | 197 053,74 | 218 314,62 |
| C. Share capital contributions (basic funds) | - | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - | - |
| Total liabilities | 321 114,71 | 244 024,85 | 282 968,40 | 219 287,11 | 231 117,67 |
| A. Equity | 163 710,51 | 83 186,22 | 53 714,15 | 52 015,90 | 52 160,76 |
| B. Liabilities and provisions for liabilities | 157 404,20 | 160 838,63 | 229 254,25 | 167 271,21 | 178 956,91 |
| I. Long-term liabilities | - | - | - | - | - |
| II. Short-term liabilities | 157 404,20 | 160 838,63 | 229 254,25 | 167 271,21 | 178 956,91 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.